Navigation Links
Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease

treatment arm, and none have been reported during the treatment


* Twenty-four out of 26 patients demonstrated an increase in a-GAL as

measured in white blood cells, kidney, and skin.

* a-GAL increases were seen in patients with both low levels of residual

enzyme activity (<3%) at baseline as well as patients presenting with

higher baseline levels (greater than or equal to 3%).

* Kidney GL-3 levels as measured in urine or biopsies were decreased in

patients who demonstrated greater increases in levels of a-GAL.

* Renal and cardiac function results were encouraging, including those

seen in patients treated for nearly two years.

* Patient responses were consistent with the results of in vitro testing

of Fabry mutations, thus improving the ability to select likely

responders for future studies.

"These data demonstrate that Amigal has a meaningful effect on a range of genetic mutations in Fabry disease and thus has the potential to treat a significant portion of the Fabry patient population," said William Wilcox, M.D., Ph.D., Director of the Metabolic Disorders Clinic at Cedars-Sinai Medical Center and a principal investigator in one of the Amigal clinical trials.

Amicus expects that the results will be presented again at the American College of Medical Genetics (ACMG) Annual Meeting on March 12-16, 2008, in Phoenix, Arizona.

Based on the results of these Phase 2 trials, Amicus and Shire plan to meet with US and European regulatory authorities to discuss the design of a Phase 3 clinical trial for Amigal.

About Fabry Disease

Fabry disease is a lysosomal storage disorder caused by inherited genetic mutations in the GLA gene, which result in deficient activity of the enzyme alpha-galactosidase A (a-GAL). Deficient a-GAL activity leads to lysosomal accumulation of globotriaosylceramide (GL-3), which is believed to cause the various s

SOURCE Amicus Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
(Date:8/28/2014)... August 28, 2014 PrimeSource Building ... materials, selected SoundConnect to support their ... based audio and web conferencing platform GlobalMeet powered ... PrimeSource’s employees’ needs. SoundConnect delivers award winning ... PrimeSource Building Products will be utilizing GlobalMeet ...
(Date:8/27/2014)... -- Rhythm, a biopharmaceutical company developing peptide therapeutics that ... metabolic disorders, announced today that it has filed a ... and Exchange Commission (SEC) relating to the proposed initial ... number of shares to be offered and the price ... Citigroup and Cowen and Company will act ...
(Date:8/27/2014)... August 27, 2014 The Global and ... study on the current state of the Trifluoroacetic Acid ... a basic overview of the industry, including definitions, applications ... domestic market analysis are provided with a focus on ... A comparison between the international and Chinese situation is ...
(Date:8/27/2014)... August 27, 2014 “We are honored ... vendors,” said Ven Thangaraj, CEO of Radiant Sage. “We ... are taking the imaging corelab market to a different ... and research organizations to efficiently and effectively manage the ... data to be analyzed and read by trained physicians. ...
Breaking Biology Technology:PrimeSource Chooses SoundConnect as Collaboration Provider 2Rhythm Files Registration Statement for Proposed Initial Public Offering 2Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at 2Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2
... , NEW YORK, Sept. 8 announces that a ... Nanomedicine , , ... This report analyzes the Global Market for Nanomedicine in Millions of US$ ... Imaging, Biomaterials, and Others. Annual forecasts are provided for the period of ...
... , ATLANTA and BRIDGEWATER, N.J. Sept. 8 From ... this year,s back to school they should also prepare for the upcoming ... new school year, the My Xperts(TM) program, created by UCB and sanofi-aventis ... outdoor nasal allergy experts to help parents prepare for fall allergy season ...
... ... , ... September 8, 2009 -- Ensuring food security for a growing world population is a ... that involves novel approaches and techniques to meet future demands, William S. Niebur ...
Cached Biology Technology:Reportlinker Adds Nanomedicine Report 2Reportlinker Adds Nanomedicine Report 3Reportlinker Adds Nanomedicine Report 4Reportlinker Adds Nanomedicine Report 5Reportlinker Adds Nanomedicine Report 6Reportlinker Adds Nanomedicine Report 7Reportlinker Adds Nanomedicine Report 8Reportlinker Adds Nanomedicine Report 9Reportlinker Adds Nanomedicine Report 10Reportlinker Adds Nanomedicine Report 11VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 2VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 3VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 4VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 5VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 6DuPont Leader Says Increasing Food Production a Moral Imperative 2DuPont Leader Says Increasing Food Production a Moral Imperative 3
(Date:8/27/2014)... cells to rearrange existing patterns of activity than when ... study of monkeys has found. The scientists explored the ... of brain cell networks. The study was partly funded ... into the brain and may have seen why it,s ... Batista, Ph.D., an assistant professor at the University of ...
(Date:8/27/2014)... want to listen carefully to someone, the first thing ... do is stop moving altogether. This strategy helps us ... own movements. , This interplay between movement and hearing ... indirect evidence has long suggested that the brain,s motor ... which gives rise to our conscious perception of sound. ...
(Date:8/27/2014)... in German . ... common inherited disease affecting the peripheral nervous system. Researchers ... Institute of Experimental Medicine and University Medical Centre Gttingen ... impaired in rats with the disease. These cells enwrap ... myelin, which facilitates the rapid transfer of electrical impulses. ...
Breaking Biology News(10 mins):Scientists plug into a learning brain 2Scientists plug into a learning brain 3Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Potential therapy for incurable Charcot-Marie-Tooth disease 2
... that prevents the body from using stored sugar has survived ... at the University of Florida putting scientists a step ... Called glycogen storage disease type 1A, the genetic disease ... use sugar between meals. In order to survive, children and ...
... Francisco, and collaborators at Harvard Medical School have linked ... that clears glucose out of the bloodstream, shedding light ... a cellular level. Establishing the function ... mice, has broad implications for both the future study ...
... for Cancer Research at the University of California, San ... of the contractile ring, a structure required for cell ... divide the cell may facilitate development of therapies to ... researchers show that even though both cell volume ...
Cached Biology News:UF makes gene therapy advance in severe genetic disorder 2UF makes gene therapy advance in severe genetic disorder 3UCSF discovers new glucose-regulating protein linked with diabetes 2Study may aid efforts to prevent uncontrolled cell division in cancer 2
... Best: DASGIPs Process Control integrates Process ... comprehensive documentation for cultivation processes. A ... pH, dissolved oxygen, temperature and agitation ... Profiles, e.g. constant or scheduled media ...
... LC Sciences provides a genome-wide microRNA ... and proprietary probe design, which enable highly ... (1-3). We have standard arrays for mature ... latest version of the Sanger miRBase database ...
... synthetic peptide whose sequences are derived from mouse resistin protein. ... - S - M - P - L - C - ... - D - K - K - I - K - ... used for neutralization and control experiments with the polyclonal antibody that ...
... Imaging System, Basic Package Superior Protein ... Range: The ProXPRESS 2D Proteomic Imaging System ... for both proteomic and general life science ... enabling the use of all dyes in ...
Biology Products: